Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation - PubMed (original) (raw)
. 1990 Dec;4(12B):2397-408.
doi: 10.1101/gad.4.12b.2397.
Affiliations
- PMID: 2149119
- DOI: 10.1101/gad.4.12b.2397
Free article
Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation
M F Laspia et al. Genes Dev. 1990 Dec.
Free article
Abstract
We studied the combined effects of Tat and general trans-activators, such as E1A and phorbol esters, on human immunodeficiency virus-1 (HIV-1) gene expression. Interaction between these two types of trans-activators may be involved in the transition from transcriptional quiesence during viral latency to active gene expression during productive infection. E1A cooperated with Tat to produce a fourfold greater increase in accumulation of full-length, cytoplasmic HIV-1-directed RNA than is expected if they were acting additively to increase RNA accumulation. Similarly, phorbol 12-myristate 13-acetate (PMA) also cooperated with Tat to elevate HIV RNA levels synergistically. Analysis of transcription rates across the HIV-1-directed transcription unit indicated, unexpectedly, that synergy between Tat and E1A could not be accounted for by increased promoter proximal transcription rates that were merely additive. However, Tat and E1A produced a greater than additive increase in transcription rates in the 3' end of the gene. These findings imply that synergy between Tat and E1A (or other general transcriptional activators) is due principally to stabilization of transcriptional elongation. Furthermore, the observation that Tat elicits only a small increase in promoter proximal transcription in the presence of E1A suggests that the magnitude of the effect of Tat on initiation is decreased when the basal level of transcription is increased. These findings underscore the importance of the ability of Tat to stabilize elongation, as well as to stimulate initiation, in an HIV-1-directed transcription unit.
Similar articles
- Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
Kessler M, Mathews MB. Kessler M, et al. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10018-22. doi: 10.1073/pnas.88.22.10018. Proc Natl Acad Sci U S A. 1991. PMID: 1658792 Free PMC article. - HIV-1 Tat protein increases transcriptional initiation and stabilizes elongation.
Laspia MF, Rice AP, Mathews MB. Laspia MF, et al. Cell. 1989 Oct 20;59(2):283-92. doi: 10.1016/0092-8674(89)90290-0. Cell. 1989. PMID: 2553266 - The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
Tiley LS, Madore SJ, Malim MH, Cullen BR. Tiley LS, et al. Genes Dev. 1992 Nov;6(11):2077-87. doi: 10.1101/gad.6.11.2077. Genes Dev. 1992. PMID: 1427073 - Multiple modes of transcriptional regulation by the HIV-1 Tat transactivator.
Marcello A, Zoppé M, Giacca M. Marcello A, et al. IUBMB Life. 2001 Mar;51(3):175-81. doi: 10.1080/152165401753544241. IUBMB Life. 2001. PMID: 11547919 Review. - Tat gets the "green" light on transcription initiation.
Brady J, Kashanchi F. Brady J, et al. Retrovirology. 2005 Nov 9;2:69. doi: 10.1186/1742-4690-2-69. Retrovirology. 2005. PMID: 16280076 Free PMC article. Review.
Cited by
- Transcriptional activity of the human immunodeficiency virus-1 LTR promoter in fission yeast Schizosaccharomyces pombe.
Toyama R, Bende SM, Dhar R. Toyama R, et al. Nucleic Acids Res. 1992 May 25;20(10):2591-6. doi: 10.1093/nar/20.10.2591. Nucleic Acids Res. 1992. PMID: 1598218 Free PMC article. - Characterization of a major histocompatibility complex class II X-box-binding protein enhancing tat-induced transcription directed by the human immunodeficiency virus type 1 long terminal repeat.
Mischiati C, Feriotto G, Borgatti M, Giacomini P, Gambari R. Mischiati C, et al. J Virol. 2000 Oct;74(19):8989-9001. doi: 10.1128/jvi.74.19.8989-9001.2000. J Virol. 2000. PMID: 10982343 Free PMC article. - RNA-targeted activators, but not DNA-targeted activators, repress the synthesis of short transcripts at the human immunodeficiency virus type 1 long terminal repeat.
Pendergrast PS, Hernandez N. Pendergrast PS, et al. J Virol. 1997 Feb;71(2):910-7. doi: 10.1128/JVI.71.2.910-917.1997. J Virol. 1997. PMID: 8995607 Free PMC article. - Tat transactivation of the human immunodeficiency virus type 1 promoter is influenced by basal promoter activity and the simian virus 40 origin of DNA replication.
Kessler M, Mathews MB. Kessler M, et al. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10018-22. doi: 10.1073/pnas.88.22.10018. Proc Natl Acad Sci U S A. 1991. PMID: 1658792 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources